Table of Contents
What does supernus do?
We are a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Over the last 30 years, we have built an extensive expertise in product development.
What drugs does supernus make?
These technologies have been utilized to create ten marketed products, including Trokendi XR® and Oxtellar XR® (Supernus), Adderall XR®, Intuniv®, and Mydayis® (developed for Shire, now Takeda), and Orenitram® (developed for United Therapeutics Corporation).
Is supernus a good company?
Great company culture and products. They are a great company with strong communication and great opportunity to get into the industry. The job provides you the ability to run and manage your day as if was your own business. They have great open communication and listen to their employees.
Who owns supernus pharmaceuticals?
Jack A. Khattar
Jack A. Khattar is the founder of Supernus Pharmaceuticals and has served as President and Chief Executive Officer and Director since 2005.
Where is supernus Pharmaceuticals located?
Rockville, MD
Supernus Pharmaceuticals is headquartered in Rockville, MD and has 2 office locations across 1 country.
How do you pronounce supernus?
Supernus Pharmaceuticals Pronunciation. Su·per·nus Phar·ma·ceu·ti·cals.
Who made Qelbree?
Supernus Pharmaceuticals has two key selling points for its newly minted Qelbree: It’s the first non-stimulant ADHD drug to win approval in a decade, and it appears to start working more quickly than its future rivals do.
How many employees does supernus?
Supernus Pharmaceuticals has 448 employees and is ranked 10th among it’s top 10 competitors.
How does Qelbree make you feel?
The most common side effects of QELBREE include: sleepiness. tiredness. vomiting. irritability.
What is Qelbree ADHD?
Qelbree (i.e. SPN-812) is a nonstimulant ADHD medication containing a serotonin norepinephrine modulating agent approved by the FDA to treat attention deficit hyperactivity disorder (ADHD or ADD) in patients 6 to 17 years of age.
Is Qelbree similar to Strattera?
Feder: Viloxazine is a norepinephrine reuptake inhibitor, similar to atomoxetine (Strattera), which was approved in 2008. Viloxazine has been studied for various indications since the 1970s.
Does Qelbree help with anxiety?
Manufactured by Supernus Pharmaceuticals, Inc., Qelbree (viloxazine extended-release capsules) is a selective norepinephrine reuptake inhibitor—a class of drugs often used to treat anxiety and depression, and sometimes ADHD. Qelbree is approved to treat young people with ADHD between the ages of 6 and 17 years.